Fill Finish Manufacturing Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
Growth Factors of Fill Finish Manufacturing Market
The fill finish manufacturing market size was valued at USD 9.04 billion in 2022, and the market is now projected to grow from USD 9.93 billion in 2023 to USD 20.42 billion by 2030, exhibiting a CAGR of 10.9% during the forecast period of 2023-2030.
The worldwide market experienced improvement during the COVID-19 occurrence. The unexpected occurrence of COVID-19 driven the necessity for therapeutics and vaccines, which augmented demand for an effective and prompt manufacturing procedure. Furthermore, the augmented sales of vaccines selected to inhibit respirational ailments also driven the worldwide fill finish manufacturing market growth.
The pharmaceutical and biotechnology companies have been scheduling to progress and manufacture novel therapeutics to control the rising problematic of long-term ailments, such as diabetes and neurological ailments. The demand for operative therapeutics and vaccines to manage prolonged diseases is also swelling intensely. Such amplified demand for therapeutics and vaccines has been appealing the necessity for widely held manufacturing of these pharmaceutical products.
The pharmaceuticals market has been mounting at a huge rate, and this feature has been intensifying the demand for fill finish manufacturing. Pharmaceutical and biotechnology firms have augmented their prominence on associations with contract manufacturing establishments to boost the manufacturing of their products.
Comprehensive Analysis of Fill Finish Manufacturing Market
The market can be segmented in various ways, depending on the focus of analysis such as by service, by sterilization and by end-user. Based on service, the market is categorized into injection filling, vials & ampoules filling, cartridge filling, and others. Based on sterilization, the market is divided into terminal sterilization and aseptic processing. Based on end-user, the market is divided into pharmaceutical companies and biotechnology companies.
North America region is dominating the fill finish manufacturing market share due to the mounting healthcare spending and robust occurrence of market performers.
The key players are enthusiastically contributing in planned events that are targeted at maintaining durable market position and growing market share by merger, partnerships and others. These players include AbbVie Inc. (U.S.), Lubrizol Life Science (U.S.), West Pharmaceutical Services, Inc. (U.S.), Eurofins Scientific (Luxembourg), Recipharm AB (Sweden), Alcami Corporation (U.S.), Boehringer Ingelheim International GmbH (Germany), Catalent, Inc. (U.S.), Baxter (U.S.), BioConnection (Netherlands) these market players spending severely on research and development in order to arise with more new technology so that they can maintain and improve their existing market.
In May 2023, West Pharmaceutical Services, Inc. initiated its manufacturing facility in Singapore to enlarge its size and fulfill clients’ demands.
Segmentation Table
ATTRIBUTE DETAILS
Study Period 2017-2030
Base Year 2022
Estimated Year 2023
Forecast Period 2023-2030
Historical Period 2017-2021
Growth Rate CAGR of 10.9% from 2023-2030
Unit Value (USD billion)
Segmentation By Service
Injection Filling
Vials & Ampoules Filling
Cartridge Filling
Others
By Sterilization
Terminal Sterilization
Aseptic Processing
By End-user
Pharmaceutical Companies
Biotechnology Companies
By Region
North America (By Sterilization, Service, End-user, and Country)
U.S.
Canada
Europe (By Sterilization, Service, End-user, and Country/Sub-region)
U.K.
Germany
France
Spain
Italy
Scandinavia
Rest of Europe
Asia Pacific (By Sterilization, Service, End-user, and Country/Sub-region)
Japan
China
Australia
India
Southeast Asia
Rest of Asia Pacific
Rest of the World (By Sterilization, Service, and End-user)
Please Note: It will take 5-6 business days to complete the report upon order confirmation.
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 3. Market Dynamics
- 3.1. Market Drivers
- 3.2. Market Restraints
- 3.3. Market Opportunities
- 3.4. Market Trends
- 4. Key Insights
- 4.1. Prevalence of Chronic Diseases – by Key Countries/Sub-region, 2021/2022
- 4.2. Overview of Fill Finish Manufacturing Services
- 4.3. Key Industry Developments (Mergers, Acquisitions, Partnerships; etc.)
- 4.4. Impact of COVID-19 on the Market
- 5. Global Fill Finish Manufacturing Market Analysis, Insights and Forecast, 2017-2030
- 5.1. Market Analysis, Insights and Forecast – By Service
- 5.1.1. Injection Filling
- 5.1.2. Vials & Ampoules Filling
- 5.1.3. Cartridge Filling
- 5.1.4. Others
- 5.2. Market Analysis, Insights and Forecast – By Sterilization
- 5.2.1. Terminal Sterilization
- 5.2.2. Aseptic Processing
- 5.3. Market Analysis, Insights and Forecast – By End-user
- 5.3.1. Pharmaceutical Companies
- 5.3.2. Biotechnology Companies
- 5.4. Market Analysis, Insights and Forecast – By Region
- 5.4.1. North America
- 5.4.2. Europe
- 5.4.3. Asia Pacific
- 5.4.4. Rest of the World
- 6. North America Fill Finish Manufacturing Market Analysis, Insights and Forecast, 2017-2030
- 6.1. Market Analysis, Insights and Forecast – By Service
- 6.1.1. Injection Filling
- 6.1.2. Vials & Ampoules Filling
- 6.1.3. Cartridge Filling
- 6.1.4. Others
- 6.2. Market Analysis, Insights and Forecast – By Sterilization
- 6.2.1. Terminal Sterilization
- 6.2.2. Aseptic Processing
- 6.3. Market Analysis, Insights and Forecast – By End-user
- 6.3.1. Pharmaceutical Companies
- 6.3.2. Biotechnology Companies
- 6.4. Market Analysis, Insights and Forecast – By Country
- 6.4.1. U.S.
- 6.4.2. Canada
- 7. Europe Fill Finish Manufacturing Market Analysis, Insights and Forecast, 2017-2030
- 7.1. Market Analysis, Insights and Forecast – By Service
- 7.1.1. Injection Filling
- 7.1.2. Vials & Ampoules Filling
- 7.1.3. Cartridge Filling
- 7.1.4. Others
- 7.2. Market Analysis, Insights and Forecast – By Sterilization
- 7.2.1. Terminal Sterilization
- 7.2.2. Aseptic Processing
- 7.3. Market Analysis, Insights and Forecast – By End-user
- 7.3.1. Pharmaceutical Companies
- 7.3.2. Biotechnology Companies
- 7.4. Market Analysis, Insights and Forecast – By Countries/ Sub-region
- 7.4.1. U.K.
- 7.4.2. Germany
- 7.4.3. France
- 7.4.4. Spain
- 7.4.5. Italy
- 7.4.6. Scandinavia
- 7.4.7. Rest of Europe
- 8. Asia Pacific Fill Finish Manufacturing Market Analysis, Insights and Forecast, 2017-2030
- 8.1. Market Analysis, Insights and Forecast – By Service
- 8.1.1. Injection Filling
- 8.1.2. Vials & Ampoules Filling
- 8.1.3. Cartridge Filling
- 8.1.4. Others
- 8.2. Market Analysis, Insights and Forecast – By Sterilization
- 8.2.1. Terminal Sterilization
- 8.2.2. Aseptic Processing
- 8.3. Market Analysis, Insights and Forecast – By End-user
- 8.3.1. Pharmaceutical Companies
- 8.3.2. Biotechnology Companies
- 8.4. Market Analysis, Insights and Forecast – By Countries/ Sub-region
- 8.4.1. Japan
- 8.4.2. China
- 8.4.3. India
- 8.4.4. Australia
- 8.4.5. Southeast Asia
- 8.4.6. Rest of Asia Pacific
- 9. Rest of the World Fill Finish Manufacturing Market Analysis, Insights and Forecast, 2017-2030
- 9.1. Market Analysis, Insights and Forecast – By Service
- 9.1.1. Injection Filling
- 9.1.2. Vials & Ampoules Filling
- 9.1.3. Cartridge Filling
- 9.1.4. Others
- 9.2. Market Analysis, Insights and Forecast – By Sterilization
- 9.2.1. Terminal Sterilization
- 9.2.2. Aseptic Processing
- 9.3. Market Analysis, Insights and Forecast – By End-user
- 9.3.1. Pharmaceutical Companies
- 9.3.2. Biotechnology Companies
- 10. Competitive Analysis
- 10.1. Global Market Share Analysis (2022)
- 10.2. Company Profiles
- 10.2.1. AbbVie Inc.
- 10.2.1.1. Overview
- 10.2.1.2. Services
- 10.2.1.3. SWOT analysis
- 10.2.1.4. Recent developments
- 10.2.1.5. strategies
- 10.2.1.6. financials (based on availability)
- 10.2.2. Lubrizol Life Science
- 10.2.2.1. Overview
- 10.2.2.2. Services
- 10.2.2.3. SWOT analysis
- 10.2.2.4. Recent developments
- 10.2.2.5. strategies
- 10.2.2.6. financials (based on availability)
- 10.2.3. West Pharmaceutical Services, Inc.
- 10.2.3.1. Overview
- 10.2.3.2. Services
- 10.2.3.3. SWOT analysis
- 10.2.3.4. Recent developments
- 10.2.3.5. strategies
- 10.2.3.6. financials (based on availability)
- 10.2.4. Eurofins Scientific
- 10.2.4.1. Overview
- 10.2.4.2. Services
- 10.2.4.3. SWOT analysis
- 10.2.4.4. Recent developments
- 10.2.4.5. strategies
- 10.2.4.6. financials (based on availability)
- 10.2.5. Recipharm AB
- 10.2.5.1. Overview
- 10.2.5.2. Services
- 10.2.5.3. SWOT analysis
- 10.2.5.4. Recent developments
- 10.2.5.5. strategies
- 10.2.5.6. financials (based on availability)
- 10.2.6. Alcami Corporation
- 10.2.6.1. Overview
- 10.2.6.2. Services
- 10.2.6.3. SWOT analysis
- 10.2.6.4. Recent developments
- 10.2.6.5. strategies
- 10.2.6.6. financials (based on availability)
- 10.2.7. Boehringer Ingelheim International GmbH
- 10.2.7.1. Overview
- 10.2.7.2. Services
- 10.2.7.3. SWOT analysis
- 10.2.7.4. Recent developments
- 10.2.7.5. strategies
- 10.2.7.6. financials (based on availability)
- 10.2.8. Catalent, Inc.
- 10.2.8.1. Overview
- 10.2.8.2. Services
- 10.2.8.3. SWOT analysis
- 10.2.8.4. Recent developments
- 10.2.8.5. strategies
- 10.2.8.6. financials (based on availability)
- 10.2.9. Baxter
- 10.2.9.1. Overview
- 10.2.9.2. Services
- 10.2.9.3. SWOT analysis
- 10.2.9.4. Recent developments
- 10.2.9.5. strategies
- 10.2.9.6. financials (based on availability)
- 10.2.10. BioConnection
- 10.2.10.1. Overview
- 10.2.10.2. Services
- 10.2.10.3. SWOT analysis
- 10.2.10.4. Recent developments
- 10.2.10.5. strategies
- 10.2.10.6. financials (based on availability)
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook